首页> 外文期刊>Biomaterials >Highly tumor-specific DNA nanostructures discovered by in vivo screening of a nucleic acid cage library and their applications in tumor-targeted drug delivery
【24h】

Highly tumor-specific DNA nanostructures discovered by in vivo screening of a nucleic acid cage library and their applications in tumor-targeted drug delivery

机译:通过体内筛选核酸笼文库的高度肿瘤特异性DNA纳米结构及其在肿瘤靶向药物递送中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Enormous efforts have been made to harness nanoparticles showing extravasation around tumors for tumor-targeted drug carriers. Owing to the complexity of in vivo environments, however, it is very difficult to rationally design a nanoconstruct showing high tumor specificity. Here, we show an approach to develop tumor-specific drug carriers by screening a library, of self-assembled nucleic acid cages in vivo, After preparation of a library of 16 nucleic acid cages by combining the sugar backbone and the shape of cages, we screened the biodistribution of the cages intravenously injected into tumor-bearing mice, to discover the cages with high tumor-specificity. This tumor specificity was found to be closely related with serum stability, cancer cell uptake efficiency, and macrophage evasion rate. We further utilized the cages showing high tumor specificity as carriers for the delivery of not only a cytotoxic small molecule drug but also a macromolecular apoptotic protein exclusively into the tumor tissue to induce tumor-specific damage. The results demonstrate that our library-based strategy to discover tumor-targeted carriers can be an efficient way to develop anti-cancer nanomedicines with tumor specificity and enhanced potency.
机译:已经对线束纳米颗粒进行了巨大的努力,显示出围绕肿瘤靶向药物载体的肿瘤的外渗。然而,由于体内环境的复杂性,非常困难地设计纳米结构,显示出高肿瘤特异性。在这里,我们通过组合糖骨架和笼形的形状,通过组合16核酸笼后,通过筛选文库,通过组合16个核酸笼中的文库,表明一种方法来发展肿瘤特异性药物载体。筛选静脉内注射到肿瘤小鼠中的笼子的生物分布,以发现具有高肿瘤特异性的笼。发现这种肿瘤特异性与血清稳定性,癌细胞吸收效率和巨噬细胞逃避率密切相关。我们进一步利用显示出高肿瘤特异性作为载体的笼子,以递送细胞毒性小分子药物,而且仅仅是大分子凋亡蛋白,其专用于肿瘤组织诱导肿瘤特异性损伤。结果表明,我们基于图书馆的抗靶载体的基于图书馆的策略可以是具有肿瘤特异性和增强效力的抗癌纳米海内西的有效方法。

著录项

  • 来源
    《Biomaterials》 |2019年第2019期|共12页
  • 作者单位

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Computat Sci Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    Seoul Natl Univ Coll Pharm 1 Gwanak Ro Seoul 08826 South Korea;

    KIST Ctr Computat Sci Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

    Purdue Univ Dept Chem W Lafayette IN 47907 USA;

    KIST Ctr Theragnosis Biomed Res Inst Hwarangno 14 Gil 5 Seoul 02792 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号